Werenfridus Adrianus Faassen,Gerardus Johannes Kemperman,Johannes Antonius van Laarhoven
申请号：
US14109633
公开号：
US20140154322A1
申请日:
2013.12.17
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides a formulation comprising asenapine hemipamoate suspended particles, which formulation can be administered via a Depot provided by an IM injection of the formulation, and which depot does not display a particle-size dependent release rate. The present invention provides also methods of treatment using the same.
